Anti-CD20 monoclonal antibodies such as Rituximab, Ofatumumab, and Obinutuzumab are widely used to treat lymphomas and autoimmune diseases. They act by depleting B cells, mainly through Fc-dependent effectors functions. Some patients develop...
Authors: Grzelak L, Roesch F, Vaysse A, Biton A, Legendre R, Porrot F, Commère P-H, Olanchais C, Mouquet H,...